EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Prognostic value of bone marrow and tumor 18 F‐FDG uptake on PET / CT in patients with oropharyngeal cancer and the interplay between inflammation and FDG uptake

Constantina Nadia Christou iD, Karl Sandström, Naresh Regula, Ylva Tiblom Ehrsson iD, Hemming Johansson, Jens Sörensen, Göran Laurell

Head & Neck · 2024

DOI: 10.1002/hed.27711 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Head & Neck, 2024. Verfasst von Constantina Nadia Christou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Sciences, Section of Otolaryngology and Head & Neck Surgery, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography, Oropharyngeal Neoplasms, Radiopharmaceuticals. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Kamprad Family Foundation for Entrepreneurship, Research and Charity, Swedish Cancer Society, Scientific Research for Junior Researchers, Uppsala University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To examine the prognostic value of F‐18 fluorodeoxyglucose (FDG) uptake in the bone marrow (BM) for disease recurrence and survival in patients with oropharyngeal squamous cell carcinoma (OP‐SCC). The secondary aims were to evaluate the prognostic value of PET/CT parameters for the primary oropharyngeal tumor and total tumor burden, and to assess the correlation between FDG uptake variables and serum inflammatory markers.

Methods

This was an observational study of 91 patients with OP‐SCC who underwent pretreatment FDG‐PET/CT. The patients' blood samples were collected before treatment, and treatment was administered with the intention to cure. The median follow‐up time was 40 months. The PET parameters measured were SUV mean BM for the assessment of BM FDG uptake, SUV mean , SUV max , total lesion glycolysis (TLG), and metabolic tumor volume (MTV) for the evaluation of primary oropharyngeal tumor and total tumor burden. Blood samples were analyzed to determine each patient's white cell, red cell, and platelet cell counts, hemoglobin, and C‐reactive protein level. In a subgroup of 33 patients, blood serum was analyzed to evaluate the expression of serum immune proteins using a proximity extension assay (Olink Proteomics).

Results

The univariate analysis revealed that SUV mean BM and tumor‐specific parameters (SUV max tumor, SUV mean total, SUV max total, MTVtotal, TLGtotal) were significantly associated with recurrence‐free survival (RFS). After adjusting for age, sex, and stage only SUV mean BM remained significantly associated with RFS. Spearman's correlation identified several correlations between PET parameters and inflammatory markers.

Conclusions

Our results show that several FDG‐PET/CT parameters may have a prognostic value of treatment outcome in patients with OP‐SCC. However, SUV mean BM was the only independent PET parameter that showed a prognostic value for RFS in the study cohort. Moreover, the study findings might suggest an association between systemic inflammation and the metabolic activity in the BM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18Positron Emission Tomography Computed TomographyOropharyngeal NeoplasmsRadiopharmaceuticalsBone MarrowHumansMaleFemaleMiddle AgedAgedPrognosisCarcinoma, Squamous CellInflammationAdultAged, 80 and overNeoplasm Recurrence, LocalTumor BurdenRetrospective Studies

Stichwörter der Autor:innen

PET/CTbone marrowhead and neck cancerinflammationoropharyngeal cancerrecurrence‐free survival

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Surgical Sciences, Section of Otolaryngology and Head & Neck Surgery, Uppsala University, Uppsala, Sweden.
  • Department of Surgical Sciences, Section of Nuclear Medicine & PET, Uppsala University, Uppsala, Sweden.
  • Department of Oncology-Pathology, Karolinska University Hospital, Stockholm, Sweden.

ORCID-Profile: Constantina Nadia Christou, Ylva Tiblom Ehrsson

Förderung

  • Kamprad Family Foundation for Entrepreneurship, Research and Charity
  • Swedish Cancer Society
  • Scientific Research for Junior Researchers, Uppsala University
  • ALF Grants at Uppsala University Hospital
  • Regionala Forskningsrådet Uppsala/Örebro
  • P. O. Zetterlings stiftelse
  • Geriatrik Foundation, Uppsala University
  • Erik, Karin, Gösta Selander Foundation

Zitieren

APA

Christou, C. N., Sandström, K., Regula, N., Ehrsson, Y. T., Johansson, H., Sörensen, J., & Laurell, G. (2024). Prognostic value of bone marrow and tumor 18 F‐FDG uptake on PET / CT in patients with oropharyngeal cancer and the interplay between inflammation and FDG uptake. Head & Neck. https://doi.org/10.1002/hed.27711

Vancouver

Christou CN, Sandström K, Regula N, Ehrsson YT, Johansson H, Sörensen J, et al. Prognostic value of bone marrow and tumor 18 F‐FDG uptake on PET / CT in patients with oropharyngeal cancer and the interplay between inflammation and FDG uptake. Head & Neck. 2024. doi:10.1002/hed.27711

BibTeX
@article{Christou2024,
  author = {Christou, Constantina Nadia and Sandström, Karl and Regula, Naresh and Ehrsson, Ylva Tiblom and Johansson, Hemming and Sörensen, Jens and Laurell, Göran},
  title = {Prognostic value of bone marrow and tumor 18 F‐FDG uptake on PET / CT in patients with oropharyngeal cancer and the interplay between inflammation and FDG uptake},
  journal = {Head & Neck},
  year = {2024},
  doi = {10.1002/hed.27711}
}
Kostenlos starten →